天然物をシードとする制がんリード化合物の合成化学的創製研究  [in Japanese] Exploration for Anti-cancer Leads through Synthetic Approach Utilizing Biologically Active Natural Products as Seed Principles  [in Japanese]

Abstract

Aiming at exploration for new anti-cancer leads utilizing biologically active natural products as seed principles, several synthetic lead compounds have been disclosed through structure-activity relationship analyses by means of a synthetic approach. 1) The absolute structure of callystatin A, potent cytotoxic polyketide, was established by comparative analysis of the CD spectra of synthetic model compounds and our first total synthesis. Furthermore, structure-activity relationship analysis using synthetic analogs revealed α,β-unsaturated δ-lactone to be pharmacophore functionality. According to the synthetic protocol of callystatin A, the first synthesis of leptomycin B, congeneric anti-tumor polyketide, was achieved to determine its absolute structure. 2) By evaluation for biological potency of synthesized amide analogs of potent cytotoxic depsipeptide arenastatin A, metabolism of 15,20-ester linkage resulted in significant reduction of anti-tumor efficacy in vivo. Modification of this ester linkage gave rise to promising leads with stability in serum as well as moderate cytotoxicity. 3) Synthesis of 4-deacetoxycongener of agosterol A, an MDR modulating polyhydroxysterol, was conducted from readily available ergosterol by way of regioselective reductive-cleavage of epoxy function developed by our group. In addition, 4-deacetoxycongener exhibited MDR modulating activity similar to agosterol A.

Journal

Natural medicines   [List of Volumes]

Natural medicines 56(3), 73-77, 2002-06-20  [Table of Contents]

The Japanese Society of Pharmacognosy

References:  14

You must have a user ID to see the references.If you already have a user ID, please click "Login" to access the info.New users can click "Sign Up" to register for an user ID.

Preview

Preview

Codes

  • NII Article ID (NAID) :
    110008732173
  • NII NACSIS-CAT ID (NCID) :
    AN10438628
  • Text Lang :
    JPN
  • Article Type :
    REV
  • ISSN :
    13403443
  • NDL Article ID :
    6207315
  • NDL Source Classification :
    ZS51(科学技術--薬学)
  • NDL Call No. :
    Z19-375
  • Databases :
    CJP  NDL  NII-ELS 

Share